Horizon Kinetics’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Horizon Kinetics's NVS Position: Q4 2018 in Review
Horizon Kinetics reduced its Novartis (NVS) stake by 0.79% in Q4 2018, selling an estimated $17.8K and leaving 28,885 shares worth $2.22M. The position accounts for 0.07% of the portfolio, ranked #102.
Horizon Kinetics first reported a position in NVS in Q2 2013 and has held it in 23 quarters since. The position peaked at $2.77M in Q3 2014. 1,088 funds tracked by Wall St. Rank hold NVS as of Q4 2018.
- Horizon Kinetics held 28,885 shares of Novartis worth $2.22M as of Q4 2018.
- Horizon Kinetics sold 229 Novartis shares in Q4 2018, an estimated $17.8K.
- Novartis made up 0.07% of Horizon Kinetics's portfolio in Q4 2018, its #102 holding.
- Horizon Kinetics first reported a position in Novartis in Q2 2013 and has held it in 23 quarters since.
- Horizon Kinetics's Novartis position peaked at $2.77M in Q3 2014.
- 1,088 funds tracked by Wall St. Rank held Novartis as of Q4 2018.
Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.